Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528456) titled 'Butylphthalide for Brain Edema After Endovascular Treatment' on April 1. Stu... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528755) titled 'Audiovisual vs Verbal Information in Third Molar Surgery' on April 1. Study ... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530081) titled 'The Impact of Oral Probiotics on Improving the Quality of Life in Patients Wi... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527689) titled 'Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529808) titled 'Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma' on Apri... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260401017) titled 'Impact of particulate matter 2.5 (PM2.5) on major cardiovascular outcomes... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528391) titled 'Comorbidity-Oriented Primary Care and Integrated Management for Hypertension ... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529873) titled 'Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients W... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530185) titled 'Effects of L-Tyrosine and Caffeine on Performance in Elite Boxers' on April 1... Read More
Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528898) titled 'Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer... Read More